Project Details
| Acronym | EFC15935 |
|---|---|
| Status | Active |
| Effective start/end date | 30/09/20 → 30/09/25 |
A randomized, multicentre, double-blind phase 3 study of SAR439859 plus palbociclib versus letrozole plus palbociclib for the treatment of patients with ER (+), HER2 (-) breast cancer who have not received prior systemic anti-cancer treatment for advanced disease
- Sabanathan, Dhanusha (Primary Chief Investigator)
- Park, John (Associate Investigator)
- Chapman, Nicola (Clinical Trial Unit Staff)
Project: Research